Amonafide in Combination With Cytarabine in Secondary AML

Clinical trial NCT00273884 · COMPLETED

Trial details

NCT number: NCT00273884
Sponsor: Xanthus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2005-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.